March 12, 2019
Dr. Ned Sharpless ’88 is on the move again. Chosen to head the National Cancer Institute in 2017, the former director of the Lineberger Comprehensive Cancer Center is set to become acting commissioner of the...Read More
Nov. 29, 2018
Carolina has reached the ranks of the top five research universities in the U.S. for federal research expenditures, according to the latest National Science Foundation Higher Education Research and Development Survey. The University posted a...Read More
Oct. 22, 2018
The University has entered into a partnership with a company that seeks to discover medicines to address significant unmet medical needs. UNC and Deerfield Management have created Pinnacle Hill LLC, in which Deerfield has committed...Read More
UNC researchers will use an $11.3 million grant to explore using nanoparticles to create cancer vaccines and improve delivery of cancer-fighting drugs and patients’ responses to them.
The five-year grant announced Monday is the third in a series of awards that the University has won from the National Cancer Institute for cancer nanotechnology research. It will fund researchers with the Carolina Center of Cancer Nanotechnology Excellence, an institute-funded collaboration between the University and the UNC Lineberger Comprehensive Cancer Center.
“UNC-Chapel Hill has emerged as a leader in nanotechnology in the last 10 years,” said Leaf Huang, a UNC Lineberger member, Fred Eshelman Distinguished Professor and interim chair of the UNC Eshelman School of Pharmacy Division of Molecular Therapeutics, and the co-leader of the cancer nanotechnology center. “This grant is a testament to the quality of our research in using nanotechnology to continue to find innovative ways to fight cancer.”
The grant will fund four studies of nanotechnology in fighting cancer: